Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity-Reference-Cited by-同舟云学术

Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

Published:2014-12-01 Issue:12 Volume:140 Page:1225
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Fojo Tito¹,Mailankody Sham¹,Lo Andrew²

Affiliation:

1. Medical Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

2. Sloan School of Management, Massachusetts Institute of Technology, Cambridge

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?;Journal of Medicinal Chemistry;2024-09-10

2. Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland: a retrospective, comparative analysis;The Lancet Oncology;2024-08

3. A Comprehensive Review of In vitro Testing and Emerging Strategies Employed in Anticancer Drug Discovery Therapy;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-26

4. Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials;2024-07-24

5. Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set;JCO Oncology Practice;2024-06